RxDoctor Payments Data

Laurie Gossard, MD

Internal Medicine · Westerville, OHNPI 1639285117

Payments from drug & device makers

$10,474in general payments, 2019–2025

Across 625 payments — averaging $16.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AbbVie$1K
  • Pfizer$844
  • Lilly USA, LLC$754
  • Amgen$503
  • Johnson & Johnson$488
  • plus $5K from 53 others

What the payments were for

  • Food & beverage$10,469100%
  • Education$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk93$1,393
AbbVie(2 entities)97$1,322
Pfizer57$844
Lilly USA, LLC42$754
Amgen29$503
Johnson & Johnson33$488
Abbott25$483
Novartis27$454
AstraZeneca18$345
Sanofi-aventis U.S. LLC19$325
Xeris Pharmaceuticals, Inc.16$318
Boehringer Ingelheim16$273
Bayer11$236
Exact Sciences10$228
Corcept Therapeutics10$219
GSK13$203
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC9$137
Merck9$132
Dexcom, Inc.6$123
Cequr Corporation3$118
Astellas Pharma US Inc6$115
E.r. Squibb & Sons, L.L.C.6$104
Medtronic3$98
Biohaven Pharmaceutical Holding Company Ltd.6$93
Amneal Pharmaceuticals LLC4$85
Radius Health, Inc.4$78
Ascendis Pharma Endocrinology Inc3$76
Esperion Therapeutics, Inc.5$71
Sanofi Pasteur Inc.3$65
Actelion Pharmaceuticals US, Inc.2$54
Boston Scientific2$52
Idorsia Pharmaceuticals US Inc3$50
Bardy Diagnostics, Inc.2$50
Lucid Diagnostics Inc.2$41
Axsome Therapeutics, Inc.2$41
Recordati_rare_diseases_inc.2$40
Phathom Pharmaceuticals, Inc.2$36
QOL Medical, LLC2$33
IBSA Pharma Inc.2$31
Corium, LLC1$30
Arbor Pharmaceuticals, Inc.2$26
Tempus AI, Inc1$26
Otsuka America Pharmaceutical, Inc.1$23
Sequel Med Tech, LLC1$22
Insulet Corporation1$19
Ascensia Diabetes Care US Inc.1$19
Amarin Pharma, Inc.1$19
Dynavax Technologies Corporation1$18
Edwards Lifesciences1$17
Irhythm Technologies, Inc.1$17
Amryt Pharma Holdings Ltd1$16
ARS Pharmaceuticals Operations, Inc.1$15
Kyowa Kirin, Inc.1$15
Shield Therapeutics Inc1$14
Teva Pharmaceuticals USA, Inc.1$14
Endo Pharmaceuticals Inc.1$14
Kowa Pharmaceuticals America, Inc.1$14
Chiesi USA, Inc.1$13
Ironshore Pharmaceuticals Inc.1$13

How this compares

$10,474 in reported general payments places this provider in the 90th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$169,153
Medicare patients
274
Services billed
5,904

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide95$102,068
EliquisApixaban76$94,404
XareltoRivaroxaban53$58,709
XifaxanRifaximin12$38,581
JardianceEmpagliflozin34$38,173
Tresiba Flextouch U-200Insulin Degludec25$33,973
FarxigaDapagliflozin Propanediol20$27,154
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$26,405
JanuviaSitagliptin Phosphate17$24,566
MounjaroTirzepatide17$19,868
Duloxetine Hcl129$6,319
Atorvastatin Calcium484$5,724
SymbicortBudesonide/Formoterol Fumarate17$5,457
SynthroidLevothyroxine Sodium85$5,289
AbrysvoRsv Vacc, Pref A And Pref B/Pf14$4,412

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,393$102,06895 claims
PfizerEliquis, Abrysvo$844$98,81690 claims
Johnson & JohnsonXarelto$488$58,70953 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$137$38,58112 claims
Boehringer IngelheimJardiance$273$38,17334 claims
AstraZenecaFarxiga, Symbicort$345$32,61137 claims
GSKTrelegy Ellipta, Shingrix$203$30,63837 claims
MerckJanuvia$132$24,56617 claims
Lilly USA, LLCMounjaro$754$19,86817 claims
AbbVieSynthroid$1,322$5,28985 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$85$3,033423 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,428 internal medicine providers in Ohio.

Other internal medicine in Westerville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →